Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.42B |
| 2 |
Vale
VALE
|
+$1.05B |
| 3 |
Freeport-McMoran
FCX
|
+$988M |
| 4 |
Micron Technology
MU
|
+$690M |
| 5 |
ExxonMobil
XOM
|
+$534M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.21B |
| 2 |
TC Energy
TRP
|
+$1.37B |
| 3 |
Microsoft
MSFT
|
+$1.32B |
| 4 |
Verizon
VZ
|
+$1.31B |
| 5 |
Amazon
AMZN
|
+$940M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 16.54% |
| 3 | Communication Services | 12.92% |
| 4 | Consumer Discretionary | 12.55% |
| 5 | Industrials | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Edwards Lifesciences
EW
$53.4B
| $687M | 0.22% |
10,777,971
-643,947
| -6% | -$36.7M |
|
|
FRC
102
DELISTED
First Republic Bank
FRC
| $682M | 0.22% |
6,787,628
-1,090
| -0% | -$107K |
|
103
Adobe
ADBE
$104B
| $680M | 0.22% |
2,549,842
+844,803
| +50% | +$213M |
|
104
BCE
BCE
$21.6B
| $644M | 0.2% |
14,493,105
+1,203,815
| +9% | +$51.9M |
|
105
Western Union
WU
$2.26B
| $636M | 0.2% |
34,408,325
-19,837
| -0.1% | -$357K |
|
106
Cisco
CSCO
$452B
| $626M | 0.2% |
11,597,005
-1,500,372
| -11% | -$72.9M |
|
|
SCHW
107
Charles Schwab
SCHW
$190B
| $615M | 0.2% |
14,394,153
+1,760,972
| +14% | +$79.5M |
|
|
GWPH
108
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $608M | 0.19% |
3,607,171
+3
| +0% | +$446 |
|
109
Toronto Dominion Bank
TD
$204B
| $607M | 0.19% |
11,180,876
+2,950,343
| +36% | +$163M |
|
110
Wells Fargo
WFC
$267B
| $604M | 0.19% |
12,492,287
-9,292,958
| -43% | -$457M |
|
111
Merck
MRK
$329B
| $598M | 0.19% |
7,532,746
-4,717,978
| -39% | -$353M |
|
112
Medtronic
MDT
$116B
| $588M | 0.19% |
6,452,384
-220,784
| -3% | -$19.8M |
|
113
AT&T
T
$167B
| $579M | 0.18% |
24,437,799
+6,645
| +0% | +$153K |
|
114
Willis Towers Watson
WTW
$31.7B
| $578M | 0.18% |
3,288,381
-77,802
| -2% | -$12.9M |
|
115
Trimble
TRMB
$13B
| $563M | 0.18% |
13,936,363
+192
| +0% | +$7.29K |
|
116
TE Connectivity
TEL
$62.2B
| $562M | 0.18% |
6,960,778
-127,469
| -2% | -$10.3M |
|
117
3M
MMM
$94B
| $560M | 0.18% |
3,225,519
+803,218
| +33% | +$135M |
|
|
LLL
118
DELISTED
L3 Technologies, Inc.
LLL
| $559M | 0.18% |
2,707,657
-187,052
| -6% | -$37.1M |
|
119
Kimberly-Clark
KMB
$36.6B
| $558M | 0.18% |
4,502,172
+457
| +0% | +$53.1K |
|
120
Sempra
SRE
$56.7B
| $541M | 0.17% |
8,590,378
+911,678
| +12% | +$53.7M |
|
|
PARA
121
DELISTED
Paramount Global Class B
PARA
| $540M | 0.17% |
11,363,106
-18,948,956
| -63% | -$923M |
|
122
Skyworks Solutions
SWKS
$10.5B
| $525M | 0.17% |
6,366,547
-2,436,371
| -28% | -$188M |
|
123
Target
TGT
$70.6B
| $522M | 0.17% |
6,507,558
+1,345
| +0% | +$98.3K |
|
124
Alcoa
AA
$13.4B
| $514M | 0.16% |
18,247,212
-384,342
| -2% | -$11M |
|
|
WBA
125
DELISTED
Walgreens Boots Alliance
WBA
| $513M | 0.16% |
8,103,290
-2,428
| -0% | -$166K |
|
Similar funds
Capital Research Global Investors's Q1 2019 Portfolio in Review
As of Q1 2019, Capital Research Global Investors held 442 positions worth $315B, up 9.9% from $287B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q1 2019 filing shows 25 new, 151 increased, 166 reduced and 27 closed positions. Its largest new stake was Micron Technology: 17,867,672 shares worth $738M. The largest sale was AbbVie, an estimated $2.21B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q1 2019 buy was Micron Technology: 17,867,672 shares worth $738M.
- Capital Research Global Investors added most to Alibaba in Q1 2019, an estimated $1.42B increase.
- Capital Research Global Investors's biggest Q1 2019 reduction was AbbVie, cutting an estimated $2.21B.
- Capital Research Global Investors fully exited TC Energy in Q1 2019, selling an estimated $1.37B.
- Capital Research Global Investors's ten largest holdings make up 27% of its $315B portfolio in Q1 2019.
- Capital Research Global Investors opened 25 new positions and closed 27 in Q1 2019.
- Capital Research Global Investors's portfolio value rose 9.9% quarter-over-quarter to $315B.
Based on Capital Research Global Investors's 13F filing for Q1 2019, filed 15 May 2019.